IV 
119TH CONGRESS 
1ST SESSION 
H. RES. 305 
Expressing support for the designation of the fourth Wednesday of February 
as ‘‘Hypertrophic Cardiomyopathy Awareness Day’’. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 8, 2025 
Mr. LAHOOD submitted the following resolution; which was referred to the 
Committee on Energy and Commerce 
RESOLUTION 
Expressing support for the designation of the fourth Wednes-
day of February as ‘‘Hypertrophic Cardiomyopathy 
Awareness Day’’. 
Whereas hypertrophic cardiomyopathy (‘‘HCM’’) is a chronic 
cardiac disease involving thickening of the heart muscle 
and can potentially lead to debilitating symptoms and se-
rious complications including heart failure, atrial fibrilla-
tion, stroke, and in rare cases sudden cardiac death; 
Whereas HCM is the most common inheritable heart disease 
and can affect anyone regardless of age, gender, or eth-
nicity with a reported prevalence ranging from 1 in 200 
to 1 in 500 in the general population; 
Whereas an estimated 700,000 to 1,650,000 people in the 
United States have HCM, yet 85 percent of them may 
remain undiagnosed; 
VerDate Sep 11 2014 
23:59 Apr 08, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR305.IH
HR305
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 305 IH 
Whereas HCM shares symptoms with other common cardio-
vascular and pulmonary diseases, such as shortness of 
breath, chest pain, fatigue, palpitations, and fainting, 
making it difficult to distinguish HCM from these other 
diseases; 
Whereas, when untreated, all-cause mortality risk is 3 to 4 
times higher in patients with HCM than that of the gen-
eral population; 
Whereas knowing one’s medical history and any signs and 
symptoms of HCM is an important first step in receiving 
an accurate diagnosis of HCM; 
Whereas a health care provider must conduct thorough 
screening with cardiac health questions to help identify a 
risk of cardiac disorders, both genetic and congenital; 
Whereas a health care provider may conduct several tests, in-
cluding an echocardiogram, a cardiac MRI, or genetic 
testing to confirm a family history of HCM, and must ex-
amine the heart to diagnose HCM; 
Whereas, following a diagnosis of HCM, it is important for 
patients to work with their health care provider to learn 
more about their disease and understand different man-
agement options, including prescription medicines and 
surgical treatment options that may help; and 
Whereas ‘‘Hypertrophic Cardiomyopathy Awareness Day’’ is 
expected to be observed in the United States for years to 
come, providing hope and information for patients, care-
givers, and families around the country: Now, therefore, 
be it 
Resolved, That the House of Representatives— 
VerDate Sep 11 2014 
23:59 Apr 08, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\HR305.IH
HR305
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 305 IH 
(1) supports the designation of ‘‘Hypertrophic 
Cardiomyopathy Awareness Day’’; 
(2) acknowledges the critical importance of hy-
pertrophic cardiomyopathy awareness to improve 
cardiovascular health; and 
(3) recognizes the need to raise public aware-
ness of the consequences of undiagnosed and un-
treated hypertrophic cardiomyopathy and urges all 
Americans to seek appropriate care. 
Æ 
VerDate Sep 11 2014 
23:59 Apr 08, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\HR305.IH
HR305
ssavage on LAPJG3WLY3PROD with BILLS